Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
who will take my grocery dollar bet, we get to 5.45 today?
we may see $2.22
prove it. what transactions?
you are speculating
understand, but avail shares really don't matter
unless he does a deal there won't be any dilution at this point
128 O/S shares, Float 50M
i don't know where you got your info
but that's the correct data according to this site (open the iBox on this page) and my broker
INOL to X__X on %__% of 48M people who will be tested at $235-1500 per test
plus, the 2-3M new Plavix users each month
this ain't no plumpy pluby plumper plumpers pilgrim
More than 2 million Americans taking Plavix — 5% of the 48 million in total — are poor metabolizers, because they didn't inherit any fully functioning copies of CYP2C19, the gene involved in converting the drug into its active form. Most don't know it, because they haven't been tested.
http://www.usatoday.com/news/health/2010-02-25-1Agenetictesting25_CV_N.htm
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=54425675
If InoLife captures JUST 5% of the existing market share for Plavix and the 6M new prescriptions in the next 3 months, this is what the stock price would be at $250 cost:
$5.56
That's EBITDA, etc. But also without a multiple.
Lop off 40% for margin of error, and it's $3.34
Imagine if 50% market share, or 80%
legend:
5%Mkt share * 9M new Plavix users 3 months = 450,000
5%Mkt share * 48M Plavix users = 2.4M
128 OS
i already did it long time ago
let me get that post
good, but add in the 48M of those current Plavix users
who will get tested also
absolutely INOL to go up
TCBY went from 4 to 1, before going to 100
be patient
this space that INOL is in is enormous
today's action? there was almost 2 hours no activity.
so I believe the seller was predetermined, into the close, once those blocks started coming was probably some bona fide seller, but also with a short seller (MM) along with it
but most importantly, someone on leverage was probably forced to sell
no surprise someone loaded up beyond their their means
my opinion
Absolutely
open your umbrella and let the oil drip over you
it's all a bunch of talk until bam, .75 cents and a whole new ballgame, and then we never hear from them again
btw: INOL traded yesterday's volume by noon today
and float has traded over twice
MM doing their best to make an exact hour before a transaction
notice the odd lot ending on the 123386 sold at 11:59
seller is probably done
Brilinta is put off for 3 more months
FDA pushes off ticagrelor decision for three more months
Written by Editorial Staff
September 16, 2010
The FDA has extended the time to complete its review of the new drug application (NDA) for ticagrelor (Brilinta, AstraZeneca) from Sept. 16 to Dec. 16.
The London-based AstraZeneca said it will “continue to work closely with the FDA to support the review of the ticagrelor NDA.”
Ticagrelor is currently under regulatory review in nine additional global territories, including the European Union, Canada and Brazil.
Ticagrelor (Brilinta/Brilique), an investigational oral antiplatelet treatment for acute coronary syndromes, is a direct-acting P2Y12 receptor antagonist in a chemical class called cyclo-pentyl-triazolo-pyrimidines.
Ticagrelor is a reversibly-binding oral ADP receptor antagonist. The PLATO (PLATelet inhibition and patient Outcomes) study found that ticagrelor decreased incidences of cardiovascular death, MI and stroke when compared with clopidogrel (Plavix, Bristol-Myers Squibb/Sanofi-Aventis)
http://www.cardiovascularbusiness.com/index.php?option=com_articles&view=article&id=24134&division=cvb
Going up today
you are wrong mr. etc etc etc
see, when a manipulator has any sort of temporary agreeableness, or one point that is salient
then he becomes licentious
here are facts to counter your lunatic enthusiasm for negativity:
1. marketing a test is selling, therefore InoLife sells a test
2. revenue is generated by sales
3. they have a product
4. the test kit is the entire process of providing the material, facilitating delivery, billing, handling to and from lab, verifying doctors with HIPAA, etc.
5. there is no scam element here, Gary is trying to build a business. he owns 45M restricted shares
6. a few of the others Genelex, etc. also farm out the labwork
7. this has everything to do with Plavix
agree
well said Chiron
btw: float turned over more than 2x since pop
yes
i also spoke with Gary
turnaround is less than 72 hours
and he has a medicare/medicaid, medical billing infrastructure in place
i couldn't get a price out of him though
can't reason with antimatter folks. INOL to $3.00!!
speculation
yes I can, that's why it's estimates, and speculation
my figures are so low, with a huge margin of error (and we still get multie dollar)
imagine when a GS or a Fidelity crunches some numbers on this
sweet numbers!!
wrong? spend your day twisting words or whatever
did you see my Projection at all: FIVE PERCENT
naturally that is not everyone
yet, MOST will likely get tested anyway, and this projection is likely short term low milestone...
here they are again!!!!
If InoLife captures JUST 5% of the existing market share for Plavix and the 6M new prescriptions in the next 3 months, this is what the stock price would be at $250 cost:
$5.56
That's EBITDA, etc. But also without a multiple.
Lop off 40% for margin of error, and it's $3.34
Imagine if 50% market share, or 80%
legend:
5%Mkt share * 9M new Plavix users 3 months = 450,000
5%Mkt share * 48M Plavix users = 2.4M
128 OS
$250 cost
Default understanding: TESTS! yes, DNA marker tests
If InoLife captures JUST 5% of the existing market share for TESTING METABOLIC RATE BECAUSE OF THE NEW FDA BLACK BOX WARNING and the 6M new prescriptions in the next 3 months, this is what the stock price would be at $250 cost:
$5.56
That's EBITDA, etc. But also without a multiple.
Lop off 40% for margin of error, and it's $3.34
Imagine if 50% market share, or 80%
legend:
5%Mkt share * 9M new Plavix users 3 months = 450,000
5%Mkt share * 48M Plavix users = 2.4M
128 OS
$250 cost
typo, it's 6M avg new Plavix pres a month
here's an estimate
and that's why it's called speculation
If InoLife captures JUST 5% of the existing market share for Plavix and the 6M new prescriptions in the next 3 months, this is what the stock price would be at $250 cost:
$5.56
That's EBITDA, etc. But also without a multiple.
Lop off 40% for margin of error, and it's $3.34
Imagine if 50% market share, or 80%
legend:
5%Mkt share * 9M new Plavix users 3 months = 450,000
5%Mkt share * 48M Plavix users = 2.4M
128 OS
$250 cost
volume volume volume
these pull backs on this volume doesn't really matter, does it?
btw, the stock has traded its float more than 2xs since pop
beentomyrasite
guys, I'm sorry, can I come back and post?
been on these boards for over two years, never a problem
thank you
Not this trip Ollie. We are going >>>/ way up
all weak hands getting... you know. they're gone. and...
consider this: huge share price upswing. why?
anyone do the math today? about $240,000 has went into the stock today, so far.
6M shares * avg .0415 (approximate)
can you imagine when a portfolio manager wants to buy $10,000,000 worth? or more?
$50M worth?
guys, and gals...
let SEAB and the rest alone. they are just clerks on this one.
when the buying begins, they won't matter.
they don't matter now, unless you are trying to trade a penny
check my other posts for where this stock price is likely going
consider this: huge share price upswing. why?
anyone do the math today? about $240,000 has went into the stock today, so far.
6M shares * avg .0415 (approximate)
can you imagine when a portfolio manager wants to buy $10,000,000 worth? or more?
$50M worth?
ok mcfly
I apologize
you accept?
consider this: huge share price upswing. why?
anyone do the math today? about $240,000 has went into the stock today, so far.
6M shares * avg .0415 (approximate)
can you imagine when a portfolio manager wants to buy $10,000,000 worth? or more?
$50M worth?
um... because you don't know what you are talking about?
could that be it?
it's been a few days, how can anyone say 'consistent pattern'
we have an OUTSIDE DAY here. if it closes above .40
it's going to the moon sooner than even I thought
this stock is going way up
i don't care how (price action-wise) it get's there
stop worrying about a few percents
it's has billion dollar potential!
hedge funds should be coming to buy
don't worry, this story will get around soon enough
it was end of summer
now that labor day has come and gone
real buying will begin
agree .5 coming soon, but even better
best to stop talking about .001 moves
this is a Dollar Stock near term
and wait til hedge fun starts buying
though they might have started today
on only 2M shares! wait until it's 20M!!
it's a dollar stock near term - be patient
U.S. Market is 38M Plavix patients
the numbers are staggering
what we need is cost and market share
here is another scenario
$200 cost, 50% market share
result: $200 * 19M / 128M OS = $29.7 price per share
share price of $1.53 for INOL
based on only 15% of U.S. Plavix patients at %50 per test